Professor of Psychiatry and Behavioral Sciences, Professor of Pediatrics, Johns Hopkins University School of Medicine
Psychiatry
Dr. Mark A. Riddle, MD
|
|
Give Review
Mark Riddle practices Psychiatry. He went to medical school at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He received awards:"America's Top Doctors", "Top Doctors:Baltimore Area" and "Top Doctors:Washington-Baltimore". Dr. Mark A. Riddle is a published MD. He has 56 publications published. The most current publication "OBSESSIVE-COMPULSIVE PERSONALITY DISORDER: EVIDENCE FOR TWO DIMENSIONS."
Publications
- Whole-genome association analysis of treatment response in obsessive-compulsive disorder.
- OBSESSIVE-COMPULSIVE PERSONALITY DISORDER: EVIDENCE FOR TWO DIMENSIONS.
- Dependent personality, separation anxiety disorder and other anxiety disorders in OCD.
- Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.
- Hoarding in Children and Adolescents with Obsessive-Compulsive Disorder.
- A practical and effective primary care intervention for treating adolescent depression.
- Clinical correlates and genetic linkage of social and communication difficulties in families with obsessive-compulsive disorder: Results from the OCD Collaborative Gen...
- Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS.
- Partitioning the heritability of tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture.
- Genome-wide association study of obsessive-compulsive disorder.
- Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1.
- The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.
- The Iron Status of Children and Youth in a Community Mental Health Clinic is Lower than that of a National Sample.
- Antipsychotic treatment patterns and aggressive behavior among adolescents in residential facilities.
- Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
- A Randomized Controlled Trial of Risperidone, Lithium, or Divalproex Sodium for Initial Treatment of Bipolar I Disorder, Manic or Mixed Phase, in Children and Adolesce...
- Antipsychotic treatment among youth in foster care.
- Cognitive functioning in compulsive hoarding.
- Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder.
- Association between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample.
- Separation anxiety disorder in OCD.
- Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders.
- Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.
- Childhood obsessive-compulsive disorder presenting as schizophrenia spectrum disorders.
- Two times four is four: OCD dimensions, classes, and categories.
- Demographic and clinical characteristics associated with treatment status in family members with obsessive-compulsive disorder.
- New onset obsessive-compulsive symptoms in children and adolescents with severe traumatic brain injury.
- Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study...
- Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (P...
- Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treat...
- Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Commentary by an academic child and adolescent psychiatrist.
- Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study.
- Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
- Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder.
- Somatic symptoms in children and adolescents with anxiety disorders.
- The OCD collaborative genetics study: methods and sample description.
- Selective serotonin reuptake inhibitor-induced apathy: a pediatric case series.
- Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology.
- The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
- Neuroimaging correlates of anxiety after pediatric traumatic brain injury.
- Paroxetine and the FDA.
- Clinical correlates of recurrent major depression in obsessive-compulsive disorder.
- Olanzapine-induced diabetes in a seven-year-old boy.
- Review of safety assessment methods used in pediatric psychopharmacology.
- How can we improve the assessment of safety in child and adolescent psychopharmacology?
- The relevance of prolonged QTc measurement to pediatric psychopharmacology.
- Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
- Benign U-wave mistaken for QTc prolongation.
- Psychotropic practice patterns for youth: a 10-year perspective.
- Anxiety after severe pediatric closed head injury.
- Obsessive-compulsive disorder: defining the phenotype.
Schools
Indiana University School of Medicine
Tulane University of Louisiana
In University Med Center Hosps
Yale School Med
Yale Child Study Center
Doctors Specialties
- Pediatric Psychiatry
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
Education
-
Yale New Haven Children's Center -
Yale University School of Medicine -
Indiana University School of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1770748972 | |
| NPPES Provider LastName | RIDDLE | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 765445095 | |
| NPPES Provider State | TX | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 67.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 35.82 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770748972 |
| Last Name Of The Provider | RIDDLE |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Carole M. Booth, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary A. Klein, MD |
|
|
Dr. Carlos A. Astrada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen E. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Sarles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Horn, MD |
|
|
Dr. Merrill I. Berman, MD |
|
|
Dr. Megan P. Della Selva, MD |
|
|
Dr. Elliot L. Hong, MD |
|
|
Dr. David B. Pruitt, MD |
|
|
Dr. Julie A. Smith, PHD |